CH415956A - Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels - Google Patents

Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels

Info

Publication number
CH415956A
CH415956A CH752561A CH752561A CH415956A CH 415956 A CH415956 A CH 415956A CH 752561 A CH752561 A CH 752561A CH 752561 A CH752561 A CH 752561A CH 415956 A CH415956 A CH 415956A
Authority
CH
Switzerland
Prior art keywords
remainder
preparation
pharmaceutical composition
composition containing
nitrogenous base
Prior art date
Application number
CH752561A
Other languages
English (en)
Inventor
W Keating John
P Collins Alfred
E Sensenbach Wilson
Original Assignee
Wallace & Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB21085/61A priority Critical patent/GB934285A/en
Priority to US117853A priority patent/US3143465A/en
Application filed by Wallace & Tiernan Inc filed Critical Wallace & Tiernan Inc
Priority to CH752561A priority patent/CH415956A/de
Priority to DEW30251A priority patent/DE1137169B/de
Priority to FR866087A priority patent/FR1414M/fr
Publication of CH415956A publication Critical patent/CH415956A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH752561A 1961-06-19 1961-06-26 Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels CH415956A (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB21085/61A GB934285A (en) 1961-06-26 1961-06-12 Pharmaceutical preparation comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon
US117853A US3143465A (en) 1961-06-19 1961-06-19 Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
CH752561A CH415956A (de) 1961-06-26 1961-06-26 Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels
DEW30251A DE1137169B (de) 1961-06-26 1961-06-26 Verfahren zur Herstellung eines pharmazeutischen Mittels
FR866087A FR1414M (fr) 1961-06-26 1961-06-26 Préparation pharmaceutique comprenant des résines échangeuses d'ions contenant du phosphore sur lesquelles est adsorbé un médicament basique, et traitement a l'aide de cette préparation pharmaceutique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH752561A CH415956A (de) 1961-06-26 1961-06-26 Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels

Publications (1)

Publication Number Publication Date
CH415956A true CH415956A (de) 1966-06-30

Family

ID=4326503

Family Applications (1)

Application Number Title Priority Date Filing Date
CH752561A CH415956A (de) 1961-06-19 1961-06-26 Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels

Country Status (3)

Country Link
CH (1) CH415956A (de)
FR (1) FR1414M (de)
GB (1) GB934285A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2063499C (en) * 1992-03-19 1996-06-18 Leon Edward St. Pierre Ingestible polymeric phosphonium salts for the lowering of blood cholesterol
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
WO2007144048A2 (en) * 2006-06-12 2007-12-21 Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg Presentation form for the oral administration of phenothiazine dyes, its production and use
WO2009007376A1 (en) * 2007-07-09 2009-01-15 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Pharmaceutical compositions for peroral administration of phenothiazine dyestuffs

Also Published As

Publication number Publication date
GB934285A (en) 1963-08-14
FR1414M (fr) 1962-07-23

Similar Documents

Publication Publication Date Title
CH473089A (de) Verfahren zur Herstellung von neuen pharmazeutischen Amino-Verbindungen
CH394494A (de) Verfahren zur Herstellung eines pharmazeutischen Vehikels
CH465225A (de) Verfahren zur Herstellung eines linearen Copolyamids
CH429724A (de) Verfahren zur Herstellung von Thiaxanthenderivaten
CH462150A (de) Verfahren zur Herstellung von 1-Aminoadamantan
CH434294A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanolderivaten
CH467289A (de) Verfahren zur Herstellung des Phosphats einer Diphenylamin-4-diazoniumbase
CH415956A (de) Verfahren zur Herstellung eines den Rest einer stickstoffhaltigen Base enthaltenden pharmazeutischen Mittels
CH413848A (de) Verfahren zur Herstellung eines neuen Imidazolinderivates
CH394215A (de) Verfahren zur Herstellung von Aminoketonderivaten
AT249885B (de) Verfahren zur Herstellung eines neuen Hexapeptids
CH415960A (de) Verfahren zur Herstellung eines desodorierend wirkenden Mittels
CH427273A (de) Verfahren zur Herstellung eines linearen Copolyamids
CH375339A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
CH376897A (de) Verfahren zur Herstellung eines neuen Sulfonylharnstoffs
CH439326A (de) Verfahren zur Herstellung von Phenyl-propylamin-Derivaten
CH412867A (de) Verfahren zur Herstellung schwefelhaltiger Naphthochinonderivate
CH421081A (de) Verfahren zur Herstellung von Monothiophosphorsäureestern
AT243998B (de) Verfahren zur Herstellung eines C40-Diindiols
AT242115B (de) Verfahren zur Herstellung von ungesättigten Verbindungen
CH388300A (de) Verfahren zur Herstellung von den B-Cyclogeranylidenrest tragenden Verbindungen
AT250572B (de) Verfahren zur Herstellung von neuen Heptapeptidderivaten
AT253147B (de) Verfahren zur Herstellung eines neuen Nonadekapeptids
CH378333A (de) Verfahren zur Herstellung eines Bis-triazinylamino-stilbens
AT225700B (de) Verfahren zur Herstellung von Phenylalkanolaminderivaten